Biotech Weekend Recap: Frustration and Disasters

Biotech Weekend Recap: Frustration And Disasters

Filed under: drug treatment news articles

… a recent article, Amarin got a big lift on Thursday (November 15th) in reaction to new information that Teva Pharmaceuticals (TEVA) was considering an acquisition of Amarin Pharmaceuticals', attempting to add the FDA-approved and soon-to-be …
Read more on Seeking Alpha

Promising Biotech Stocks With Upcoming FDA Catalysts

Filed under: drug treatment news articles

Biogen is a more established biotech company with five FDA approved drugs already on the market. This makes the company less risky among the others featured in this article. Biogen's Avonex, Fampyra and Tysabri are on the market to treat multiple …
Read more on Seeking Alpha

Players In Hepatitis C Treatment Market Officially In Play

Filed under: drug treatment news articles

Earlier this week, the company was basking in the glow of encouraging tests results for its new treatment for the liver disease hepatitis C. Abbott (ABT) said Monday that its drug regimen cured 99 percent of patients in a midstage study with the most …
Read more on Seeking Alpha